ArticleScientific reports2026
Hypericin and berberine promote elongation of hair peg-like sprouting in hair follicle organoids via oxytocin signaling activation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxytocin is a hormone produced during childbirth and lactation. Moreover, it is expressed in both men and women during physical contact with family members and pets. Oxytocin influences various organs and tissues, including the heart, digestive system, and reproductive organs. We recently demonstrated that oxytocin acts on hair follicles to promote hair growth. However, owing to its large molecular weight and poor skin permeability, small-molecule alternatives are required for its practical application as a hair growth-promoting agent. In this study, we comprehensively investigated molecules that increase oxytocin receptor expression and those that act as receptor agonists to identify compounds with oxytocin-like activity. Using in vitro 2D culture of dermal papilla cells and in silico screening based on binding affinity for the oxytocin receptor, we identified hypericin as a compound that enhances oxytocin receptor expression and berberine as an oxytocin receptor agonist. The additive effects of hypericin and berberine on hair growth promotion were further demonstrated using hair follicle organoid-based assays. These findings highlight the potential of hypericin and berberine to act as small-molecule alternatives to oxytocin and should contribute to the development of novel therapeutic strategies for hair-loss diseases such as alopecia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.